£10.2M
The seed round was co-led by Octopus Ventures and redalpine to support preclinical candidate selection and pipeline development.
ExpressionEdits
ExpressionEdits uses artificial intelligence and proprietary intron technology to optimise protein expression.
£10.2MTotal raised
ExpressionEdits develops a computational gene editing platform that uses artificial intelligence and proprietary intron technology to optimise protein expression. The biotechnology firm operates from its headquarters in Cambridge.
Categories
Founders
KT
Kärt Tomberg
CEO & Co-Founder